Would blockage of cytokines improve the outcome of pancreatic islet transplantation?

被引:13
作者
Amoli, MM [1 ]
Larijani, B [1 ]
机构
[1] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Tehran, Iran
关键词
D O I
10.1016/j.mehy.2005.08.057
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
It has been estimated that up to 60% of pancreatic islet tissue undergoes apoptosis within the first several days post-transplantation. This strongly suggests the involvement of an inflammatory event other than alloantigenspecific immune reaction following islet transplantation which contributes to partial destruction of grafts. Inflammatory cytokines including IL-1 beta, TNF-alpha and IFN-gamma are implicated in the pancreatic islet beta-cell death and functional loss during autoimmune diabetes and also seem to be involved in early toss of islet mass in islet transplantation. Inflammatory cytokines and free oxygen radicals released in situ could cause apoptosis and the functional impairment of islets after islet transplantation and graft failure. It can be hypothesized that preventing destruction of transplanted islets using cytokine blockade could be helpful in improving islet transplantation outcome. Several approaches have been made based on this hypothesis to examine the effect of inflammatory blockade on the islets survival and functional islet mass. Further investigations are required to identify most efficient way for block of cytokine-induced damage in pancreatic islets transplantation. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:816 / 819
页数:4
相关论文
共 34 条
[11]   Activated protein C preserves functional islet mass after intraportal transplantation -: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death [J].
Contreras, JL ;
Eckstein, C ;
Smyth, CA ;
Bilbao, G ;
Vilatoba, M ;
Ringland, SE ;
Young, C ;
Thompson, JA ;
Fernández, JA ;
Griffin, JH ;
Eckhoff, DE .
DIABETES, 2004, 53 (11) :2804-2814
[12]   NITRIC-OXIDE MEDIATES CYTOKINE-INDUCED INHIBITION OF INSULIN-SECRETION BY HUMAN ISLETS OF LANGERHANS [J].
CORBETT, JA ;
SWEETLAND, MA ;
WANG, JL ;
LANCASTER, JR ;
MCDANIEL, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) :1731-1735
[13]   PREVENTION OF DIABETES IN NOD MICE TREATED WITH ANTIBODY TO MURINE IFN-GAMMA [J].
DEBRAYSACHS, M ;
CARNAUD, C ;
BOITARD, C ;
COHEN, H ;
GRESSER, I ;
BEDOSSA, P ;
BACH, JF .
JOURNAL OF AUTOIMMUNITY, 1991, 4 (02) :237-248
[14]   ENDOGENOUS NITRIC-OXIDE INDUCED BY INTERLEUKIN-1-BETA IN RAT ISLETS OF LANGERHANS AND HIT-T15 CELLS CAUSES SIGNIFICANT DNA-DAMAGE AS MEASURED BY THE COMET ASSAY [J].
DELANEY, CA ;
GREEN, MHL ;
LOWE, JE ;
GREEN, IC .
FEBS LETTERS, 1993, 333 (03) :291-295
[15]   Adult porcine islets produce MCP-1 and recruit human monocytes in vitro [J].
Ehrnfelt, C ;
Kumagai-Braesch, M ;
Uzunel, M ;
Holgersson, J .
XENOTRANSPLANTATION, 2004, 11 (02) :184-194
[16]  
Eizirik DL, 1996, DIABETOLOGIA, V39, P875
[17]   Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-1β-induced B-cell impairment and activation of islet cell apoptosis in vitro [J].
Giannoukakis, N ;
Rudert, WA ;
Ghivizzani, SC ;
Gambotto, A ;
Ricordi, C ;
Trucco, M ;
Robbins, PD .
DIABETES, 1999, 48 (09) :1730-1736
[18]   Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation [J].
Johansson, H ;
Lukinius, A ;
Moberg, L ;
Lundgren, T ;
Berne, C ;
Foss, A ;
Felldin, M ;
Källen, R ;
Salmela, K ;
Tibe, A ;
Tufveson, G ;
Ekdahl, KN ;
Elgue, G ;
Korsgren, O ;
Nilsson, B .
DIABETES, 2005, 54 (06) :1755-1762
[19]   Inflammatory mediators expressed in human Islets of Langerhans: implications for Islet transplantation [J].
Johansson, U ;
Olsson, A ;
Gabrielsson, S ;
Nilsson, B ;
Korsgren, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (03) :474-479
[20]  
MANDRUPPOULSEN T, 1987, ACTA PATH MICRO IM C, V95, P55